Kolexia
Mathey Guillaume Neurologie
Mathey Guillaume
Neurologie
Hôpital Central
Nancy, France
109 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Sclérose en plaques récurrente-rémittente Sclérose en plaques chronique progressive Neuromyélite optique COVID-19 Sarcoïdose Maladies du système nerveux central Leucoencéphalopathies

Collaborateurs

Voir plus
Debouverie Marc
Debouverie Marc
Hôpital Central, Nancy, France
De Sèze Jérôme
De Sèze Jérôme
Hôpital Hautepierre, Strasbourg, France
Frenay Christine
Frenay Christine
Hôpital Pasteur, Nice, France
Pittion-Vouyovitch Sophie
Pittion-Vouyovitch Sophie
Hôpital Central, Nancy, France

Industries

Voir plus
Biogen
3 collaboration(s)
Dernière en 2022
Merck-Serono
3 collaboration(s)
Dernière en 2022
Sanofi
3 collaboration(s)
Dernière en 2023
Novartis
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis: An Adaptive Phase 2a/2b, Randomized, Double-Blind, Parallel-Group Study to Investigate the Safety and Efficacy of LY3541860 Compared to Placebo in Slowing the Occurrence of New T1 Gadolinium-Enhancing Lesions in Adult Participants With Relapsing Multiple Sclerosis
Essai Clinique (Lilly)   19 mars 2024
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.
Journal of neurology   29 février 2024
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Multiple sclerosis (Houndmills, Basingstoke, England)   15 février 2024
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)   02 janvier 2024
Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients.
Therapeutic advances in neurological disorders   23 décembre 2023
Performance of administrative databases for identifying individuals with multiple sclerosis.
Scientific reports   25 octobre 2023
STOP-I-SEP: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Essai Clinique (CHU Rennes)   23 octobre 2023
TOTEM-RRMS: TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
Essai Clinique (Grünenthal)   23 octobre 2023
Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.
Journal of neurology   31 août 2023
The radiologically isolated syndrome: revised diagnostic criteria.
Brain : a journal of neurology   03 août 2023